Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
11,981,347
-
Share change
-
-73,158
-
Total reported value
-
$8,958,000
-
Put/Call ratio
-
0%
-
Price per share
-
$0.78
-
Number of holders
-
23
-
Value change
-
-$92,576
-
Number of buys
-
9
-
Number of sells
-
15
Institutional Holders of ACURA PHARMACEUTICALS INC - COM NEW (ACUR) as of Q3 2014
As of 30 Sep 2014,
ACURA PHARMACEUTICALS INC - COM NEW (ACUR) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,981,347 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Creative Planning, Financial Advisory Service, Inc., NORTHERN TRUST CORP, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, RENAISSANCE TECHNOLOGIES LLC, BlackRock Fund Advisors, and Mariner Wealth Advisors, LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.